[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:dilated-cardiomyopathy:bag3-gene":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Dilated Cardiomyopathy","BAG3 Gene",3,[8,16,23],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07137338","A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy",[12],"Phase 1","RECRUITING","2026-08-26T02:15:43.339060Z","2026-05-05T02:35:31.899551Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT07218887","ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy",[20],"Phase 1\u002FPhase 2","2026-08-26T02:17:24.721169Z","2026-05-05T02:35:31.597951Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07426419","An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM)",[20],"2026-08-26T02:15:11.740957Z","2026-06-14T18:39:22.247454Z"]